Kenneth E. Schmader

Prof. Kenneth E. Schmader

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2014 in Wound Repair and Regeneration
Verified
Journal Article
Closed access
PDF file
LGLisa Gould
Lisa Gould
PAPeter Abadir
Peter Abadir
HBHarold Brem
Harold Brem
MCMarissa Carter
Marissa Carter
TCTeresa Conner‐Kerr
Teresa Conner‐Kerr
KSKenneth E. Schmader
Kenneth E. Schmader

1 August 2016 in Clinics in Geriatric Medicine
Verified
Journal Article
Closed access
KSKenneth E. Schmader
Kenneth E. Schmader

14 February 2022 in Psychotherapy and Psychosomatics
Verified
Journal Article
Closed access
PDF file
JHJoseph T. Hanlon
Joseph T. Hanlon
KSKenneth E. Schmader
Kenneth E. Schmader
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

22 November 2019 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Closed access
PDF file
MHMarion Hemmersbach-Miller
Marion Hemmersbach-Miller
BABarbara D. Alexander
Barbara D. Alexander
CPCarl F. Pieper
Carl F. Pieper
KSKenneth E. Schmader
Kenneth E. Schmader

28 March 2019 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
MHMarion Hemmersbach-Miller
Marion Hemmersbach-Miller
BABarbara D. Alexander
Barbara D. Alexander
DSDebra L. Sudan
Debra L. Sudan
CPCarl Pieper
Carl Pieper
KSKenneth E. Schmader
Kenneth E. Schmader

22 March 2023 in Pain
Verified
Journal Article
Open access
DHDavid Hohenschurz-Schmidt
David Hohenschurz-Schmidt
DCDan Cherkin
Dan Cherkin
ARAndrew P. Rice
Andrew P. Rice
RDRobert H. Dworkin
Robert H. Dworkin
DTDennis C. Turk
Dennis C. Turk
JVJan Vollert
Jan Vollert
Many questions regarding the clinical management of people experiencing pain and related health policy decision-making may best be answered by pragmatic controlled trials. To generate clinically relevant and widely applicable findings, such trials aim to reproduce elements of routine clinical care or are embedded within clinical workflows. In contrast with traditional efficacy trials, pragmatic trials are intended to address a broader set of external validity questions critical for stakeholders (clinicians, healthcare leaders, policymakers, insurers, and patients) in considering the adoption and use of evidence-based treatments in daily clinical care. This article summarizes methodological considerations for pragmatic trials, mainly concerning methods of fundamental importance to the internal validity of trials. The relationship between these methods and common pragmatic trials methods and goals is considered, recognizing that the resulting trial designs are highly dependent on the specific research question under investigation. The basis of this statement was an Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) systematic review of methods and a consensus meeting. The meeting was organized by the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public–private partnership. The consensus process was informed by expert presentations, panel and consensus discussions, and a preparatory systematic review. In the context of pragmatic trials of pain treatments, we present fundamental considerations for the planning phase of pragmatic trials, including the specification of trial objectives, the selection of adequate designs, and methods to enhance internal validity while maintaining the ability to answer pragmatic research questions.